Grewia asiatica
Grewia asiatica · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Grewia asiatica is a versatile plant species primarily recognized for the diverse therapeutic potential of its fruit. Scientific investigations into its aqueous, methanolic, and fruit pulp extracts have revealed significant medicinal properties, including anti-HIV, anticarcinomic, antifeedant, and antiflu activities. The plant plays a crucial role in managing complex health conditions such as cancer, hypertension, and regulating the glycemic index. Furthermore, its bioactive compounds have shown promise in enhancing physiological processes like phagocytosis. Through these various preparations, Grewia asiatica continues to be a subject of intense interest in pharmacological research.
- Synonyms
- Grewia Hainesiana · Grewia Subinaequalis · 1 more
- Common names
- Not available
- Family
- Malvaceae
- Distribution
- Africa
- Plant Parts
- Fruit
Classification
Common Names
Grewia asiatica is a versatile plant known by many different names across various languages and cultures. In English-speaking regions, it is most frequently referred to as Falsa or phalsa. Its identity shifts slightly depending on the local dialect, appearing as Cò ke Á châu in certain contexts. In Central Europe, the species is recognized by the name grévia ázijská. Furthermore, it is identified in Slavic-speaking areas as Гревия азиатская.
Sources: Catalogue of Life (COL)
Synonyms
Grewia asiatica is a complex species that encompasses several recognized botanical synonyms. Within its taxonomic history, it has been identified under the name Grewia asiatica var. pierrei. Additionally, the plant is linked to the synonym Grewia hainesiana in various scientific records. Further classification has also included the name Grewia subinaequalis as a variant of this species. Understanding these relationships is essential for accurate identification and botanical study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Grewia asiatica belongs to the vast kingdom Plantae, representing the diverse world of multicellular organisms. Within this kingdom, it is classified under the class Equisetopsida, which highlights its fundamental botanical structure. The plant is further organized into the order Malvales, a group that shares specific evolutionary traits. Moving down the taxonomic hierarchy, it is a member of the family Malvaceae, connecting it to a wide array of related species. Finally, its precise identity is defined by its placement within the genus Grewia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malvales |
| Family | Malvaceae |
| Genus | Grewia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Grewia asiatica exhibits a diverse geographical range that spans across multiple continents and climate zones. In the African region, this species is found throughout the Western Indian Ocean, including the islands of Mauritius and Réunion. Its presence extends into the temperate regions of Western Asia, specifically within the country of Iran. Moving into tropical landscapes, the plant thrives across the Indian Subcontinent, with notable populations in Assam and Bangladesh. This wide distribution highlights the plant's adaptability to both temperate and tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Grewia asiatica grows in a sturdy shrub form that remains naturally self-supporting. This resilient plant typically reaches a maximum height of 4 meters. Its compact structure makes it a distinctive feature in various landscapes.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Grewia asiatica serves as a potent tool for managing health by modulating the production of reactive oxygen species (ROS) within the blood. The fruit also plays a crucial role in regulating blood glucose metabolism, characterized by its low glycemic index and modest hypoglycemic activity. Beyond metabolic control, this plant has demonstrated significant utility in both the prevention and treatment of cancer within validated preclinical models. Additionally, the fruit provides cardiovascular benefits by acting as an antihypertensive agent through vasodilation and nitric oxide-mediated pathways. These diverse pharmacological properties confirm that the plant effectively treats issues ranging from high blood pressure to glycemic instability.
Preparations
Grewia asiatica is prepared as an aqueous extract from its root bark to study its analgesic and anti-inflammatory effects in rodents. The plant is also processed as a methanolic extract of the bark to undergo phytochemical testing and pharmacological screening. Additionally, Grewia asiatica is prepared as fruit pulp extracts (FPEs) to investigate its potential for ameliorating testicular histopathology. These various preparation methods allow researchers to explore the diverse therapeutic properties of the plant. Each specific extraction technique targets different medicinal benefits ranging from pain relief to reproductive protection.
Parts used
Grewia asiatica is a significant medicinal plant known for producing edible fruits that offer various health benefits. Research indicates that extracts from the fruit of this species can help ameliorate testicular histopathology caused by carbon tetrachloride exposure in mice. Furthermore, the fruit has demonstrated antihypertensive properties by promoting vasodilation through nitric oxide-mediated pathways. In human studies, the fruit also shows a low glycemic index and can modulate the production of reactive oxygen species in the blood. These diverse pharmacological activities highlight the therapeutic potential of the Grewia asiatica fruit in managing cardiovascular and metabolic conditions.